FRINDOVYX FDA approval date

The FDA approved FRINDOVYX on 7 Jun 2023.

FDA approval date
7 Jun 2023

Drug identity has not yet been verified against registry records

Also recorded as CYCLOPHOSPHAMIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-06-07DayFRINDOVYXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210852", "applicant_as_listed_by_fda": "AVYXA HOLDINGS", "brand_names": ["FRINDOVYX"], "active_ingredients": ["CYCLOPHOSPHAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230607", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026